Position in DHR
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$60,094,099
New position
Shares Held
316,952
first reported quarter
Ownership
0.045%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Vanguard Investments Australia, Ltd. holds $296,231,087 across 30 Diagnostics & Research names. DHR ranks #2 (20.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
187,317 | $92,071,925 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
316,952 | $60,094,099 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
39,868 | $22,401,430 | |
| 4 | A |
Agilent Technologies, Inc.
|
141,198 | $16,093,748 | |
| 5 | WAT |
Waters Corp /De/
|
49,145 | $14,635,381 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
85,306 | $14,548,085 | |
| 7 | NTRA |
Natera, Inc.
|
65,147 | $13,028,748 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
10,112 | $12,753,254 |
All Filings in DHR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $60,094,099 | 316,952 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||